Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Baird analyst Michael Ha maintains Astrana Health (NASDAQ:ASTH) with a Outperform and raises the price target from $54 to $67.
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from...
2024 Guidance:Taking all of Astrana's recent growth initiatives and capital allocation strategy into account, the Company i...
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.40 per share which missed the analyst consensus estimate of $0.4...
Stifel analyst Craig Jones maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $48 to $60.
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 StatesExpands Payer-Agnostic Car...
Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NA...
